Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Sullenger

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 21, 2020
Controlling cancer-induced inflammation with a nucleic acid scavenger prevents lung metastasis in murine models of breast cancerEda K Holl, Victoria Frazier, Karenia Landa, et al.
Cancers|May 16, 2023
An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor PathwayXirui Song, Haixiang Yu, Cynthia Sullenger, et al.
Plastic and Reconstructive Surgery|August 28, 2014
The nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation tissue contractionEda K Holl, Jennifer E Bond, Maria A Selim, et al.
Plos One|January 20, 2021
IL-10 and class 1 histone deacetylases act synergistically and independently on the secretion of proinflammatory mediators in alveolar macrophagesBrent A Stanfield, Todd Purves, Scott Palmer, et al.
The Journal of Clinical Investigation|December 7, 2007
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in miceJames O McNamara, Despina Kolonias, Fernando Pastor, et al.
Nature Reviews. Materials|March 7, 2022
Design of therapeutic biomaterials to control inflammationZhaoxu Tu, Yiling Zhong, Hanze Hu, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2017
Aptamers in Bordeaux, 24-25 June 2016Jean-Jacques Toulmé, Paloma H Giangrande, Günter Mayer, et al.
Frontiers in Neurology|October 24, 2024
Von Willebrand factor targeted thrombolysis in canine basilar artery occlusionArianna Carfora, Blake Holthaus, Simon Yacoub, et al.
Frontiers in Immunology|August 14, 2023
Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasmsAustin M Eckhoff, Michael C Brown, Karenia Landa, et al.
Biomaterials|March 29, 2022
DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonistsIbtehaj Naqvi, Nicholas Giroux, Lyra Olson, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 21, 2020
Controlling cancer-induced inflammation with a nucleic acid scavenger prevents lung metastasis in murine models of breast cancerEda K Holl, Victoria Frazier, Karenia Landa, et al.
Cancers|May 16, 2023
An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor PathwayXirui Song, Haixiang Yu, Cynthia Sullenger, et al.
Plastic and Reconstructive Surgery|August 28, 2014
The nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation tissue contractionEda K Holl, Jennifer E Bond, Maria A Selim, et al.
Plos One|January 20, 2021
IL-10 and class 1 histone deacetylases act synergistically and independently on the secretion of proinflammatory mediators in alveolar macrophagesBrent A Stanfield, Todd Purves, Scott Palmer, et al.
The Journal of Clinical Investigation|December 7, 2007
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in miceJames O McNamara, Despina Kolonias, Fernando Pastor, et al.
Nature Reviews. Materials|March 7, 2022
Design of therapeutic biomaterials to control inflammationZhaoxu Tu, Yiling Zhong, Hanze Hu, et al.
Pharmaceuticals (Basel, Switzerland)|January 25, 2017
Aptamers in Bordeaux, 24-25 June 2016Jean-Jacques Toulmé, Paloma H Giangrande, Günter Mayer, et al.
Frontiers in Neurology|October 24, 2024
Von Willebrand factor targeted thrombolysis in canine basilar artery occlusionArianna Carfora, Blake Holthaus, Simon Yacoub, et al.
Frontiers in Immunology|August 14, 2023
Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasmsAustin M Eckhoff, Michael C Brown, Karenia Landa, et al.
Biomaterials|March 29, 2022
DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonistsIbtehaj Naqvi, Nicholas Giroux, Lyra Olson, et al.
Pageof 2